Search
170 studies match these filters. Showing 26–50 of 170 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 1,142 sites in total · contact listed | Recruiting | Phase 3 | 11,800target | 1,142 / 51 | 2025 | Nov 12, 2026 | |
| NCT06424288 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empag… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 672 sites in total · contact listed | Recruiting | Phase 3 | 6,712target | 672 / 30 | 2024 | Nov 12, 2026 | |
| NCT07415031 | A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorect… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 101 sites in total · contact listed | Recruiting | Phase 2 | 170target | 101 / 21 | 2026 | Nov 12, 2026 | |
| NCT07516444 | VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial) Pivotal trial to evaluate the safety and clinical efficacy of the VDyne TriNova System for the treatment of symptomatic severe or greater tricuspid regurgitation. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 12 sites in total · contact listed | Recruiting | Not applicable | 520target | 12 / 1 | 2026 | Nov 10, 2026 | |
| NCT06561386 | A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1% ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 330 sites in total · contact listed | Recruiting | Phase 3 | 1,000target | 330 / 31 | 2024 | Nov 9, 2026 | |
| NCT03723928 | S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as t… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 723 sites in total | Recruiting | Not applicable | 739target | 723 / 3 | 2018 | Nov 9, 2026 | |
| NCT06215716 | A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The study will enroll subjects in two cohorts for a total samples size of 1650 subjects. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 361 sites in total | Recruiting | Phase 3 | 1,650target | 361 / 18 | 2023 | Nov 6, 2026 | |
| NCT06742723 | A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 771 sites in total | Recruiting | Phase 3 | 5,000target | 771 / 42 | 2025 | Nov 6, 2026 | |
| NCT03899155 | Pan Tumor Rollover Study Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 410 sites in total | Recruiting | Phase 2 | 1,500target | 410 / 38 | 2019 | Nov 6, 2026 | |
| NCT06915233 | A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle The objective of this study is to demonstrate the superiority of MACI (autologous cultured chondrocytes on porcine collagen membrane) versus Bone Marrow Stimulation in the treatment of patients aged 17 to 65 years with symptomatic articular chondral or osteochondral defects of the talus. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 12 sites in total · contact listed | Recruiting | Phase 3 | 309target | 12 / 1 | 2026 | Nov 5, 2026 | |
| NCT07282665 | A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing the number of C. difficile infections (pCDI) in adults 65 years of age or older. The participants will receive either the C. difficile vaccine or placeb… ✓ Contact✗ Claimed Nearest site: Newton, Kansas, United States — 53 km away · 185 sites in total | Recruiting | Phase 3 | 32,500target | 185 / 4 | 2025 | Nov 5, 2026 | |
| NCT07353931 | Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight The YDAN master protocol will support two independent studies, J3R-MC-YOA1 and J3R-MC-YOA2. Each study will investigate how well and safely Eloralintide (LY3841136) works in adults with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last abo… ✓ Contact✗ Claimed Nearest site: Newton, Kansas, United States — 53 km away · 147 sites in total · contact listed | Recruiting | Phase 3 | 900target | 147 / 13 | 2026 | Nov 4, 2026 | |
| NCT05174169 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 1,085 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 1,912target | 1,085 / 3 | 2022 | Nov 4, 2026 | |
| NCT05633654 | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 378 sites in total | Recruiting | Phase 3 | 1,514target | 378 / 12 | 2022 | Nov 4, 2026 | |
| NCT05080673 | Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps This trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10 years compared to participants randomized to surveillance colonoscopy at 5 and 10 years. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 499 sites in total · contact listed | Recruiting | Not applicable | 9,500target | 499 / 2 | 2022 | Nov 4, 2026 | |
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 751 sites in total · contact listed | Recruiting | 2,900target | 751 / 1 | 2022 | Nov 4, 2026 | ||
| NCT07293247 | A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment This phase II trial compares the effect of intensity-modulated post-operative radiation therapy (I²-PORT) followed by standard of care therapy (chemotherapy or immunotherapy) to standard of care therapy alone in treating patients with non-small cell lung cancer (NSCLC) who have remaining lymph node… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 125 sites in total · contact listed | Recruiting | Phase 2 | 164target | 125 / 1 | 2026 | Nov 3, 2026 | |
| NCT06750094 | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovor… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 251 sites in total | Recruiting | Phase 3 | 700target | 251 / 26 | 2024 | Nov 3, 2026 | |
| NCT06662786 | A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxaliplatin (mFOLFOX6) or 5-fluorouracil, leucovorin calcium (folini… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 239 sites in total | Recruiting | Phase 3 | 1,000target | 239 / 22 | 2024 | Nov 3, 2026 | |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia This phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a chemotherapy dr… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 460 sites in total | Recruiting | Phase 3 | 303target | 460 / 2 | 2017 | Nov 3, 2026 | |
| NCT07196722 | A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 395 sites in total | Recruiting | Phase 2 / Phase 3 | 1,092target | 395 / 28 | 2025 | Nov 3, 2026 | |
| NCT02523014 | Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma that is growing, spreading, or getting worse (progressive). Vismodegib, FAK inhibitor GSK2256098, capivasertib, and abemaciclib may stop the g… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 791 sites in total | Recruiting | Phase 2 | 124target | 791 / 1 | 2015 | Nov 3, 2026 | |
| NCT06319820 | A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 193 sites in total | Recruiting | Phase 3 | 641target | 193 / 20 | 2024 | Nov 3, 2026 | |
| NCT07321652 | Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL This phase III trial compares the effect of adding sonrotoclax to zanubrutinib versus zanubrutinib alone for the treatment of patients with untreated chronic lymphoblastic leukemia (CLL)/small lymphocytic lymphoma (SLL). Sonrotoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhib… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 261 sites in total · contact listed | Recruiting | Phase 3 | 466target | 261 / 1 | 2026 | Nov 3, 2026 | |
| NCT07225946 | A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer The purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of treatment until disease worsens as determined by scans or death due to any cause) when compared to treatment with docetaxe… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 165 sites in total | Recruiting | Phase 3 | 800target | 165 / 17 | 2025 | Nov 3, 2026 |